Factor Bioscience
Cambridge, US · Delaware LLC
Factor Bioscience develops mRNA, gene-editing, and cell-reprogramming technologies for cell engineering, including tools to repair disease-causing mutations and engineer immune cells to fight cancer. It works with strategic pharmaceutical and biotech partners across product development stages, from target identification through cell line development and manufacturing in its cleanrooms.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2025
▶$1MraisedSep 2025 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedSep 2025 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew AngelExecutive Officer, Director
- Christopher RohdeDirector
- Offering amount
- $5M
- Amount sold
- $1M
- First sale
- Sep 2025
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlap
Twist Bioscience18 shared keywordsTwist Bioscience develops a silicon-based synthetic DNA manufacturing platform that produces high-quality DNA, genes, and NGS reagents for customers in medicine, agriculture, and industrial chemicals. The platform enables faster and more affordable DNA synthesis at scale with customizable high-throughput capabilities.
Generate Biomedicines14 shared keywordsGenerate:Biomedicines develops protein-based therapeutics using artificial intelligence and machine learning in a field it calls Generative Biology, combining computational protein design with biological engineering. The company creates new drugs on demand across diverse biologic modalities for immunology, oncology, infectious disease, and vaccines.
Life Biosciences13 shared keywordsLongevity company with diversified therapies to extend healthy human lifespan
Transition Bio13 shared keywordsTransition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease. The company is a platform-based biotherapeutics developer founded on academic research from the University of Cambridge.
Precision BioSciences12 shared keywordsPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).
Companies competing with Factor Bioscience for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Factor Bioscience do?
- Factor Bioscience develops mRNA, gene-editing, and cell-reprogramming technologies for cell engineering, including tools to repair disease-causing mutations and engineer immune cells to fight cancer. It works with strategic pharmaceutical and biotech partners across product development stages, from target identification through cell line development and manufacturing in its cleanrooms.
- Who founded Factor Bioscience?
- Factor Bioscience was founded by Christopher Rohde, Matt Angel.
- How much funding has Factor Bioscience raised?
- Factor Bioscience has disclosed $1M raised across 1 round.
- Where is Factor Bioscience headquartered?
- Factor Bioscience is headquartered in Cambridge, US.